To include your compound in the COVID-19 Resource Center, submit it here.

Abraxane nab-paclitaxel: Phase II data

An open-label, Canadian Phase II trial in 40 evaluable patients showed that 260 mg/m

Read the full 144 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE